Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

September 01, 1985; Volume 28,Issue 3
  • You have access
    Homologous desensitization of the beta-adrenergic receptor. Functional integrity of the desensitized receptor from mammalian lung.
    R H Strasser, R A Cerione, J Codina, M G Caron and R J Lefkowitz
    Molecular Pharmacology September 1985, 28 (3) 237-245;
  • You have access
    Bicycloorthocarboxylate convulsants. Potent GABAA receptor antagonists.
    J E Casida, C J Palmer and L M Cole
    Molecular Pharmacology September 1985, 28 (3) 246-253;
  • You have access
    Phenyliminoimidazolidines. Characterization of a class of potent agonists of octopamine-sensitive adenylate cyclase and their use in understanding the pharmacology of octopamine receptors.
    J A Nathanson
    Molecular Pharmacology September 1985, 28 (3) 254-268;
  • You have access
    Barbiturates decrease voltage-dependent calcium conductance of mouse neurons in dissociated cell culture.
    M A Werz and R L Macdonald
    Molecular Pharmacology September 1985, 28 (3) 269-277;
  • You have access
    Uptake of the glutathione conjugate S-(1,2-dichlorovinyl)glutathione by renal basal-lateral membrane vesicles and isolated kidney cells.
    L H Lash and D P Jones
    Molecular Pharmacology September 1985, 28 (3) 278-282;
  • You have access
    Major differences in the specificity and regulation of mouse renal cytochrome P-450-dependent monooxygenases. A comparison of xenobiotic and endogenous substrates.
    R L Hawke and R M Welch
    Molecular Pharmacology September 1985, 28 (3) 283-289;
  • You have access
    Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo.
    J Halpert, C Balfour, N E Miller, E T Morgan, D Dunbar and L S Kaminsky
    Molecular Pharmacology September 1985, 28 (3) 290-296;
  • You have access
    High affinity binding of [3H]acetylcholine to muscarinic receptors. Regional distribution and modulation by guanine nucleotides.
    D Gurwitz, Y Kloog and M Sokolovsky
    Molecular Pharmacology September 1985, 28 (3) 297-305;
  • You have access
    Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity.
    E Albano, M Rundgren, P J Harvison, S D Nelson and P Moldéus
    Molecular Pharmacology September 1985, 28 (3) 306-311;
  • You have access
    Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the rat.
    S A Wrighton, E G Schuetz, P B Watkins, P Maurel, J Barwick, B S Bailey, H T Hartle, B Young and P Guzelian
    Molecular Pharmacology September 1985, 28 (3) 312-321;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 28, Issue 3
1 Sep 1985
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Characterization of GRD and LCCH3 from Human Louse
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics